PCN60 VALUE OF NEOADJUVANT IO THERAPIES WITH OR WITHOUT ADJUVANT CANCER THERAPIES: A MODEL FRAMEWORK
نویسندگان
چکیده
منابع مشابه
Adjuvant systemic therapies in breast cancer.
Although some women with early breast cancer (BC) may be cured with loco-regional treatment alone, up to 20% of patients with early-stage BC will ultimately experience treatment failure and recurrence. A substantial portion of the success in improving clinical outcomes of patients with BC is related to the standardized use of adjuvant therapies. The identification of tumor subtypes with prognos...
متن کاملAdjuvant Therapies of Pemphigus Vulgaris: A Review
Pemphigus vulgaris (PV) is an autoimmune disease characterized by blistering and erosions on skin and mucous membranes due to acantholysis. It is caused by autoantibodies against desmosomal caderins desmoglein 3 (Dsg 3) which are calcium dependent cell adhesion molecules. The measurement of Dsg 3-ELISA had been shown to be a sensitive and specific test for the diagnosis of PV in addition to the...
متن کاملSelective TRAIL-induced apoptosis in dysplastic neoplasia of the colon may lead to new neoadjuvant or adjuvant therapies.
In this issue of Clinical Cancer Research , Jalving et al. (1) shows that treatment with recombinant human tumor necrosis factor (TNF)–related apoptosis-inducing ligand (TRAIL) triggers apoptosis in human dysplastic colorectal adenomas of the colon. These observations suggest the potential to develop neoadjuvant or adjuvant therapies for susceptibility syndromes and may in the future involve in...
متن کاملNeoadjuvant, surgery and adjuvant chemotherapy without radiation for esophageal cancer.
BACKGROUND A phase II trial to evaluate neoadjuvant (NAD), surgery and adjuvant (AD) combination chemotherapy without radiation therapy (RT) for patients with esophageal adenocarcinoma staged with endoscopic ultrasound and CT as T3N1 was carried out. METHODS Thirty-three eligible patients were enrolled. NAD therapy was administered in two 49-day cycles and included cisplatin, floxuridine, pac...
متن کاملAdvanced cell therapies with and without scaffolds.
Tissue engineering and regenerative medicine aim to produce tissue substitutes to restore lost functions of tissues and organs. This includes cell therapies, induction of tissue/organ regeneration by biologically active molecules, or transplantation of in vitro grown tissues. This review article discusses advanced cell therapies that make use of scaffolds and scaffold-free approaches. The first...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Value in Health
سال: 2019
ISSN: 1098-3015
DOI: 10.1016/j.jval.2019.09.257